4D Molecular Therapeutics (FDMT) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for 4D Molecular Therapeutics (FDMT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 3.05M (-96.42%) | 85M (+94444.44%) | 90K (+350.00%) | 20K (+100.00%) | 10K | - | - | 10K (-66.67%) | 30K | -20.00K | 20M (+8316.67%) | 240K (-20.00%) | 300K (-76.00%) | 1.25M (+150.00%) | 500K (+212.50%) | 160K (-86.89%) | 1.22M (+1255.56%) | 90K (-93.43%) | 1.37M (-90.60%) | 15M (+629.00%) | 2.00M | -980.00K | 7.42M (+111.40%) | 3.51M (+2.93%) | 3.41M |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 65M (+12.79%) | 58M (+16.53%) | 49M (+3.11%) | 48M (+17.81%) | 41M (-5.55%) | 43M (+11.98%) | 38M (+20.78%) | 32M (+14.32%) | 28M (+7.07%) | 26M (+3.83%) | 25M (+6.32%) | 24M (+5.22%) | 22M (+4.18%) | 22M (+13.57%) | 19M (-7.25%) | 20M (+5.37%) | 19M (+10.55%) | 18M (+10.67%) | 16M (+4.07%) | 15M (+19.19%) | 13M (+1.27%) | 13M (+9.08%) | 12M (-26.46%) | 16M (+19.45%) | 13M |
Selling General And Administrative | 12M (-8.46%) | 13M (+7.85%) | 12M (+2.78%) | 12M (-10.97%) | 13M (-0.69%) | 13M (+3.00%) | 13M (+19.34%) | 11M (+3.01%) | 10M (-2.92%) | 11M (+16.36%) | 9.11M (+3.64%) | 8.79M (+10.01%) | 7.99M (-5.56%) | 8.46M (+4.96%) | 8.06M (-1.35%) | 8.17M (-0.73%) | 8.23M (+12.28%) | 7.33M (-10.50%) | 8.19M (+17.84%) | 6.95M (+25.45%) | 5.54M (-19.01%) | 6.84M (+85.87%) | 3.68M (+20.26%) | 3.06M (-16.16%) | 3.65M |
Operating Expenses | 77M (+8.94%) | 70M (+14.85%) | 61M (+3.04%) | 59M (+10.87%) | 54M (-4.42%) | 56M (+9.74%) | 51M (+20.44%) | 42M (+11.27%) | 38M (+4.18%) | 37M (+7.17%) | 34M (+5.56%) | 32M (+6.51%) | 30M (+1.43%) | 30M (+11.00%) | 27M (-5.56%) | 29M (+3.55%) | 28M (+11.06%) | 25M (+3.45%) | 24M (+8.34%) | 22M (+21.14%) | 18M (-5.86%) | 19M (+27.62%) | 15M (-18.85%) | 19M (+11.72%) | 17M |
Depreciation And Amortization | 1.27M (+22.12%) | 1.04M (-20.00%) | 1.30M (0.00%) | 1.30M (+23.81%) | 1.05M (-2.78%) | 1.08M (-10.00%) | 1.20M (0.00%) | 1.20M (+2.56%) | 1.17M (+19.39%) | 980K (-10.91%) | 1.10M (0.00%) | 1.10M (+6.80%) | 1.03M (+3.00%) | 1.00M (+100.00%) | 500K (0.00%) | 500K (+21.95%) | 410K (+20.59%) | 340K (-15.00%) | 400K (0.00%) | 400K (+5.26%) | 380K (+26.67%) | 300K (-25.00%) | 400K (0.00%) | 400K (+17.65%) | 340K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -73.62M | 15M | -61.18M (+2.89%) | -59.46M (+10.89%) | -53.62M (-4.45%) | -56.12M (+9.76%) | -51.13M (+20.42%) | -42.46M (+11.33%) | -38.14M (+4.07%) | -36.65M (+162.35%) | -13.97M (-56.53%) | -32.14M (+6.74%) | -30.11M (+4.84%) | -28.72M (+8.42%) | -26.49M (-6.82%) | -28.43M (+7.73%) | -26.39M (+6.58%) | -24.76M (+9.27%) | -22.66M (+198.16%) | -7.60M (-53.40%) | -16.31M (-20.13%) | -20.42M (+161.13%) | -7.82M (-48.38%) | -15.15M (+14.08%) | -13.28M |
Ebit | -73.62M | 15M | -61.18M (+2.89%) | -59.46M (+10.89%) | -53.62M (-4.45%) | -56.12M (+9.76%) | -51.13M (+20.42%) | -42.46M (+11.33%) | -38.14M (+4.07%) | -36.65M (+162.35%) | -13.97M (-56.53%) | -32.14M (+6.74%) | -30.11M (+4.84%) | -28.72M (+8.42%) | -26.49M (-6.82%) | -28.43M (+7.73%) | -26.39M (+6.58%) | -24.76M (+9.27%) | -22.66M (+198.16%) | -7.60M (-53.40%) | -16.31M (-20.13%) | -20.42M (+161.13%) | -7.82M (-48.38%) | -15.15M (+14.08%) | -13.28M |
EBITDA | -72.35M | 16M | -59.88M (+2.96%) | -58.16M (+10.63%) | -52.57M (-4.49%) | -55.04M (+10.23%) | -49.93M (+21.01%) | -41.26M (+11.63%) | -36.96M (+3.59%) | -35.68M (+177.23%) | -12.87M (-58.54%) | -31.04M (+6.74%) | -29.08M (+4.91%) | -27.72M (+6.66%) | -25.99M (-6.95%) | -27.93M (+7.46%) | -25.99M (+6.43%) | -24.42M (+9.70%) | -22.26M (+209.17%) | -7.20M (-54.80%) | -15.93M (-20.83%) | -20.12M (+171.16%) | -7.42M (-49.69%) | -14.75M (+14.08%) | -12.93M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 4.86M (+3.40%) | 4.70M (+8.55%) | 4.33M (-10.91%) | 4.86M (-12.90%) | 5.58M (-13.76%) | 6.47M (-11.25%) | 7.29M (-3.44%) | 7.55M (+31.30%) | 5.75M (+31.28%) | 4.38M (+12.89%) | 3.88M (+54.58%) | 2.51M (+74.31%) | 1.44M (+7.46%) | 1.34M (+67.50%) | 800K (+135.29%) | 340K (+240.00%) | 100K | -310.00K | 440K (+4300.00%) | 10K (0.00%) | 10K | - | - | 10K (-92.31%) | 130K |
Net Interest Income | 4.86M (+3.40%) | 4.70M (+8.55%) | 4.33M (-10.91%) | 4.86M (-12.90%) | 5.58M (-13.76%) | 6.47M (-11.25%) | 7.29M (-3.44%) | 7.55M (+31.30%) | 5.75M (+31.28%) | 4.38M (+12.89%) | 3.88M (+54.58%) | 2.51M (+74.31%) | 1.44M (+7.46%) | 1.34M (+67.50%) | 800K (+135.29%) | 340K (+240.00%) | 100K | -310.00K | 440K (+4300.00%) | 10K (0.00%) | 10K | - | - | 10K (-92.31%) | 130K |
Other Non Operating Income | - | -40.00K (+100.00%) | -20.00K (-66.67%) | -60.00K | 70K | -80.00K | - | -40.00K (+300.00%) | -10.00K (-94.44%) | -180.00K (+12.50%) | -160.00K | 10K | -20.00K (-50.00%) | -40.00K | 10K | - | -50.00K (-58.33%) | -120.00K (+1100.00%) | -10.00K | - | -100.00K (-44.44%) | -180.00K (+800.00%) | -20.00K (0.00%) | -20.00K (+100.00%) | -10.00K |
Net Income | |||||||||||||||||||||||||
Net Income From Continuing Operations | -68.76M | 19M | -56.88M (+4.06%) | -54.66M (+13.95%) | -47.97M (-3.42%) | -49.67M (+13.30%) | -43.84M (+25.44%) | -34.95M (+7.87%) | -32.40M (+0.37%) | -32.28M (+214.62%) | -10.26M (-65.36%) | -29.62M (+3.28%) | -28.68M (+4.75%) | -27.38M (+6.58%) | -25.69M (-8.54%) | -28.09M (+6.64%) | -26.34M (+5.02%) | -25.08M (+12.77%) | -22.24M (+193.02%) | -7.59M (-53.75%) | -16.41M (-20.15%) | -20.55M (+162.45%) | -7.83M (-48.32%) | -15.15M (+15.12%) | -13.16M |
Net Income | -68.76M | 19M | -56.88M (+4.06%) | -54.66M (+13.95%) | -47.97M (-3.42%) | -49.67M (+13.30%) | -43.84M (+25.44%) | -34.95M (+7.87%) | -32.40M (+0.37%) | -32.28M (+214.62%) | -10.26M (-65.36%) | -29.62M (+3.28%) | -28.68M (+4.75%) | -27.38M (+6.58%) | -25.69M (-8.54%) | -28.09M (+6.64%) | -26.34M (+5.02%) | -25.08M (+12.77%) | -22.24M (+193.02%) | -7.59M (-53.75%) | -16.41M (-20.15%) | -20.55M (+162.45%) | -7.83M (-48.32%) | -15.15M (+15.12%) | -13.16M |
Comprehensive Income Net Of Tax | -69.67M (-50.10%) | -139.61M (+146.92%) | -56.54M (+3.46%) | -54.65M (+14.16%) | -47.87M (-70.20%) | -160.65M (+278.27%) | -42.47M (+20.86%) | -35.14M (+8.02%) | -32.53M (-67.35%) | -99.62M (+889.28%) | -10.07M (-65.28%) | -29.00M (+4.47%) | -27.76M (-74.36%) | -108.27M (+321.12%) | -25.71M (-9.76%) | -28.49M (+4.21%) | -27.34M (-61.89%) | -71.74M (+219.84%) | -22.43M (+195.52%) | -7.59M (-53.75%) | -16.41M (-71.05%) | -56.69M (+624.01%) | -7.83M | - | - |